Stay updated with breaking news from Lightspeed Early Access Program. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The global small-scale bioreactors market is predicted to register a CAGR of 14.8% over the forecast period, as per FMI’s analysis. The industry’s size is anticipated to increase from US$ 1.94 billion in 2023 to US$ 7.71 billion by 2033 end.New therapies are expected to be increasingly developed in the coming years...
In part 1 of this two-part article, Jason C. Foster, CEO and executive director of Ori Biotech, and Abe Maingi, VP of business development and...
The global small-scale bioreactors market is predicted to register a CAGR of 14.8% over the forecast period, as per FMI’s analysis. The industry’s size is anticipated to increase from US$ 1.94 billion in 2023 to US$ 7.71 billion by 2033 end.New therapies are expected to be increasingly developed in the coming years...
Ori Biotech (Ori), a leader in cell and gene therapy (CGT) manufacturing technologies, and the Cell Therapy Manufacturing Center (CTMC), a joint venture between National Resilience Inc and MD Anderson Cancer Center, today announce a collaborative partnership to develop industrial manufacturing processes for cell ...
Ori Biotech Ltd, an innovator in the cell and gene therapy (CGT) manufacturing sphere, has secured over US$100m in an oversubscribed Series B funding round.